Multicenter retrospective study of thrombolytic therapy including AT-III for portal vein thrombosis

Multicenter retrospective study of thrombolytic therapy including AT-III for portal vein thrombosis - Efficacy and safety of AT-III for portal vein thrombus

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044249

Enrollment

200

Registered

2021-05-18

Start date

2021-03-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

portal vein thrombus

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who received thrombolytic therapy for portal vein thrombosis 2. Age: 18 years old and over 3. Gender: It doesn't matter

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Response rate and elimination rate of thrombolysis	—

Countries

Japan

Contacts

Public ContactKorenobu Hayama

Noppn Medical School Chibahokusoh Hospital division of gastroenterology

leaf0710@nms.ac.jp0476991111

Outcome results